Spire Healthcare Group (LON:SPI) had its price objective cut by research analysts at Berenberg Bank from GBX 310 ($4.28) to GBX 290 ($4.01) in a report issued on Thursday. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price target would indicate a potential upside of 37.05% from the stock’s previous close.
Several other equities research analysts have also weighed in on SPI. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 339 ($4.68) target price on shares of Spire Healthcare Group in a report on Thursday, January 4th. Liberum Capital reaffirmed a “hold” rating and issued a GBX 270 ($3.73) target price on shares of Spire Healthcare Group in a report on Tuesday, January 16th. Numis Securities reissued an “add” rating and set a GBX 296 ($4.09) price objective on shares of Spire Healthcare Group in a report on Tuesday, January 16th. Jefferies Group raised shares of Spire Healthcare Group to a “buy” rating and increased their price objective for the stock from GBX 259 ($3.58) to GBX 290 ($4.01) in a report on Wednesday, January 17th. Finally, Barclays started coverage on shares of Spire Healthcare Group in a report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.73) price objective on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of GBX 283.17 ($3.91).
Shares of Spire Healthcare Group stock opened at GBX 211.60 ($2.92) on Thursday. Spire Healthcare Group has a fifty-two week low of GBX 206.40 ($2.85) and a fifty-two week high of GBX 362.10 ($5.00). The firm has a market cap of $874.36 and a PE ratio of 5,290.00.
In related news, insider Justin Ash acquired 46,500 shares of the firm’s stock in a transaction on Tuesday, March 6th. The shares were purchased at an average price of GBX 215 ($2.97) per share, with a total value of £99,975 ($138,125.17).
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.